American Society for Peripheral Nerve American Society for Peripheral Nerve
MEMBER LOGIN
Username:
Password:
 
 
SEARCH ASPN WEBSITE
ASPN 2019 Annual Meeting
February 1-3, 2019
JW Marriott Hotel
Palm Desert, California

ASPN 2020 Annual Meeting
January 10-12, 2020
Marriott Harbor Beach
Fort Lauderdale, Florida

ASPN 2021 Annual Meeting
January 15 – 17, 2021
Grand Hyatt Kaua'i Resort
Koloa, Hawaii

ASPN Videos and Recordings on PSEN
ASPN members have complimentary access.
Visit psenetwork.org.

 
QUICK LINKS

Back to 2015 Annual Meeting Program


Optimization of Decellularized Nerve Allografts: Comparison of Rat and Human Nerves
Caroline A. Hundepool, MSc1; Dimitra Kotsougiani, MD1; Patricia F. Friedrich, AAS1; Steven E.R. Hovius, MD, PhD2; Allen T. Bishop, MD1; Alexander Y. Shin, MD1
1Department of Orthopedic Surgery, Microvascular Research Laboratory, Mayo Clinic, Rochester, MN; 2Department of Plastic, Reconstructive and Handsurgery, Erasmus MC, University Medical Center, Rotterdam, Netherlands

Introduction: In previous animal studies, commercially available processed nerve allografts have been inferior to autograft nerve for motor recovery. We hypothesize that different processing and storage techniques may better maintain nerve ultrastructure, lower immunogenicity, and minimize cellular debris, resulting in an ‘optimized’ processed nerve. We tested several modifications to previously-described processing and storage protocols in both fresh rat sciatic and human sensory and motor nerves. The protocols evaluated used chemical detergents and irradiation as previously described, with the addition of variable exposure to the highly potent enzyme Elastase.

Materials & Methods: For this experiment 50 rat nerves and 70 human sensory and motor nerves were processed, followed by storage at either 4 or -80 °C for the duration of two weeks. Both processed and fresh control nerves were analyzed using immunohistochemical stainings and confocal microscopy. We evaluated basal lamina (laminin ?-1), Schwann cells (S100 protein) and immunogenicity (major histocompatibility complex class I, MHC-I). Ultrastructural integrity and amount of cellular debris were analyzed on cross-sections of the nerves stained with toluidine blue and by electron microscopy.

Results: Nerve gross morphology and internal structure and basal lamina were preserved with all decellularization protocols. Storage at -80°C severely altered nerve ultrastructure after any decellularization method. Elastase was found to significantly reduce the immunogenicity (MHC-I) and the amount of Schwann cells (S100), while maintaining good structural properties. Increased concentrations of the enzyme enhanced the decellularization process. It also significantly diminished cellular debris. Significant differences were found between rat and human nerve outcomes using the different decellularization protocols. However, both showed the same negative effect of the freeze storage of the nerve after the decellularization process.

Conclusions: Elastase, when added to nerve processing reduced its immunogenicity, diminished cellular debris and better removed Schwann cells while maintaining ultrastructure. Storage at -80° heavily damaged nerve ultrastructure. A following in vivo study will be needed to demonstrate superior functional outcome with the optimized processed nerve allograft.


Back to 2015 Annual Meeting Program
 
  CONTACT US
American Society for Peripheral Nerve
500 Cummings Center, Suite 4400, Beverly, MA 01915
Phone 978-927-8330  |  Email ASPN
© 2018 ASPN | Privacy Policy